Predictors of severe morbidity and death after elective abdominal aortic aneurysmectomy in patients with chronic obstructive pulmonary disease  by Upchurch, Gilbert R. et al.
Predictors of severe morbidity and death after
elective abdominal aortic aneurysmectomy in
patients with chronic obstructive pulmonary
disease
Gilbert R. Upchurch, Jr, MD, Mary C. Proctor, MS, Peter K. Henke, MD, Paul Zajkowski,
Eric M. Riles, Michael S. Ascher, Matthew J. Eagleton, MD, and James C. Stanley, MD, Ann Arbor, Mich
Objective: This study sought to identify risk factors associated with an unfavorable outcome after elective abdominal aortic
aneurysm (AAA) repair in patients with chronic obstructive pulmonary disease (COPD).
Methods: The clinical records of 158 patients who underwent elective open AAA repair with COPD determined from
preadmission International Classification of Diseases–ninth revision codes during a 12-year period at the University of
Michigan were reviewed. Patients with uncomplicated outcomes (group I) were compared with those with unfavorable
postoperative outcomes (group II). The unfavorable outcomes were defined as myocardial infarction, acute renal failure,
worsening respiratory insufficiency necessitating tracheostomy, or death within 30 days of surgery. Logistic regression
analyses of variables that were identified as being statistically significant in the univariate analysis were used to develop a
predictive model of these events.
Results: Group I included 133 patients (77 men, 56 women) with a mean age of 70.1 years, and group II included 25
patients (13 men, 12 women) with a mean age of 71.4 years. Preoperative factors statistically related (P  .002) to an
unfavorable outcome in group II patients included: suboptimal COPD management (fewer prescribed inhalers), lower
hematocrit, preoperative renal insufficiency, and coronary artery disease. Importantly, abnormal preoperative spirometry
and arterial blood gases were not predictive of a poor outcome. Univariate analysis also revealed increased hospital (25
versus 13 days; P  .0001) and intensive care unit (14 versus 4 days; P  .001) length of stays and a greater need for
prolonged ventilation (8 versus 1 day; P  .039) for group II patients compared with group I patients. The 30-day
mortality rate in the entire experience was 3.2% (5/158). No specific variables associated with mortality were identified.
Conclusion: Fewer prescribed inhalers, lower hematocrit, renal insufficiency, and coronary artery disease are preoperative
factors associated with unfavorable outcomes after open elective surgical repair of AAA in patients with COPD. Intensive
management of these factors may reduce the hazards of AAA operations in these patients. COPD alone should not be
considered a deterrent to the surgical treatment of AAAs. (J Vasc Surg 2003;37:594-9.)
Chronic obstructive pulmonary disease (COPD) is as-
sociated with development of an abdominal aortic aneu-
rysm (AAA) and early rupture of small aneurysms.1,2
COPD has also been perceived as a relative contraindica-
tion to open AAA repair on the basis of increased operative
morbidity and mortality.3 Acceptance of this assumption as
factual may result in denial of treatment to these patients
perceived to be at high risk.
A recent study of Veterans Administration patients
with an administrative dataset failed to link COPD to
increased operative mortality rate (odds ratio, 1.1; P 
.81). Morbidity rate, however, was higher. Patients with
COPD had prolonged lengths of hospital and intensive
care unit (ICU) stay and a more frequent need for pro-
longed mechanical ventilation. These results suggested that
COPD is associated with a more complex postoperative
course as measured with surrogate endpoints. The objec-
tive of this study was to review the postoperative experience
of patients with COPD who underwent elective open AAA
repair at a single institution and to identify preoperative or
perioperative risk factors associated with an unfavorable
outcome.
METHODS
One hundred sixty-nine patients who underwent elec-
tive repair of a nonruptured AAA (International Classifica-
tion of Diseases–ninth revision [ICD-9] code 441.4) at the
University of Michigan Hospital from 1988 to 2000 were
selected from 758 elective AAA procedures. Patients were
included if they had a concurrent diagnosis of COPD (496,
493.2, 492.8, 491.21, 491.20) that defined chronic airway
obstruction, chronic bronchitis, emphysema, and chronic
asthma. Medical records were reviewed to verify the ICD-9
coding and obtain additional data for the study. Eleven
patients were excluded because of insufficient data for
analysis. None of these 11 patients had a poor postoperative
outcome. This study was approved by the University of
Michigan Medical School Institutional Review Board
(1999-504).
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All patients underwent evaluation in the preoperative
anesthesia clinic and additional pulmonary or cardiac eval-
uation at the discretion of the attending faculty. Patients
were identified as having cardiac or renal disease, diabetes,
or hypertension. Medications for underlying concurrent
conditions were only included if they were listed in the
preoperative assessment. The study covers a 12-year period,
and standard practices have changed, but the following are
operational practices applied throughout the study. AAA
repair was routinely performed with a transperitoneal ap-
proach with combined general endotracheal and epidural
anesthesia. A preoperative serum creatinine level of 1.2
mg/dL defined the upper limit of normal renal function,
but acute renal failure in the postoperative period was
defined as at least a tripling of the preoperative creatinine
level or the acute need for dialysis. Traditional parameters
for weaning patients from the ventilator could not always
be used with this population of patients with COPD.
Decisions regarding the need for permanent tracheostomy
were made on an individual basis in conjunction with
consultation with the pulmonary service.
The medical records of the 169 patients were reviewed
(by authors PZ, EMR, and MSA) with a standardized data
collection form to collect 104 variables. These included
preoperative evaluation of the pulmonary status and cur-
rent management of COPD, arterial blood gas values, and
pulmonary function data. Perioperative factors included
the size and location of the aneurysm, the length and type
of procedure, the use of epidural anesthesia, fluid manage-
ment, the highest recorded intraoperative pulmonary artery
pressure, the lowest cardiac output, and operative compli-
cations. Postoperative outcome measures, such as hospital
length of stay, time in the ICU, need for reintubation,
routine metabolic and hematologic laboratory data, post-
operative adverse events, and discharge status, were also
included.
Patients were stratified into two groups according to
their postoperative course. Group I patients had uncompli-
cated postoperative courses, and group II patients had
major complications that included death within 30 days of
operation, new myocardial infarction verified with positive
cardiac enzymes, renal failure indicated with a creatinine
level at least three times the preoperative value or the need
for dialysis, or the necessity for a permanent tracheostomy.
Univariate analyses (t tests for continuous data and
Fisher exact test for dichotomous outcomes) were per-
formed to identify associations between the variables and
patient outcomes. Those with a significant P value (.05)
were entered into a backward logistic regression model to
determine factors that were independently associated with
patient outcome. Data were analyzed with SAS v 8.1 (SAS,
Cary, NC).
RESULTS
One hundred thirty-three patients had uncomplicated
courses (group I). Twenty-five had significant complica-
tions (group II). These events and the rate of their occur-
rences were not rare (Table I). Groups I and II were similar
with respect to most preoperative factors, including age,
weight, and smoking history. Hypertension and congestive
heart failure occurred more frequently in group II, but the
difference did not reach statistical significance (Table II).
The mean preoperative serum creatinine level was statisti-
cally different between the groups (1.3 mg/dL in group I
versus 2.2 mg/dL in group II; P  .006) as was the
diagnosis of coronary artery disease (CAD; 53% in group I
versus 79% in group II; P  .02) and hematocrit (39% in
group I versus 34% in group II; P  .001).
The diameter of the AAAs ranged from 3 cm to 12.5
cm, with an average of 5.8 cm. Aneurysms were character-
ized as either infrarenal (n  127) or pararenal (n  31).
The infrarenal group tended to have slightly larger lesions
(6 cm versus 5.7 cm), but the difference was not statistically
significant. No association between the location of the
aneurysm and outcome was evident, with pararenal aneu-
rysms noted in seven of the 25 group II patients and 24 of
the 133 group I patients (P  .27) Specifically, no associ-
ations were seen between location and death, renal failure,
dialysis, or myocardial infarction.
Preoperative and postoperative spirometry and arterial
blood gas data were available for 50% and 58% of the
patients, respectively. The decision to obtain these studies
was made at the discretion of the attending physician.
Table I. Summary of significant complications
(excluding mortality)
All patients Group II
Myocardial infarction 4.4% 29%
Acute renal failure 8.8% 58%
Hemodialysis 3.8% 25%
Tracheostomy 4.4% 29%
Table II. Preoperative characteristics in patients with







Age (y) 70.1 71.4
Gender (male:female) 77:56 13:12
Weight (kg) 78 78
History of smoking 97% 100%
Current smoker 32% 30%
Hypertension 66% 83%








82% versus 18% 72% versus 28%
AAA diameter (cm) 5.8 6.0
*P  .05, group I compared with group II.
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Importantly, groups I and II did not differ with respect to
preoperative and postoperative pulmonary function data
and arterial blood gas measurements (Figure). The groups
also had similar patterns of home oxygen and steroid use.
However, more patients in group I had prescribed inhalers
(51% in group I versus 25% in group II; P .03), suggest-
ing that their COPD may have been treated more aggres-
sively (Table III). The overwhelming majority (98%) of
patients in this series were either past or current smokers.
Therefore, smoking could not be related to different out-
comes in this study.
Epidural anesthesia was used in addition to endotra-
cheal anesthesia in 92% of patients in each group (Table
IV). A transverse incision was used in 60% of cases. A
statistical difference in outcomes was not associated with
either the type of anesthesia or type of incision (Table IV).
Group II patients had a greater volume of blood replace-
ment accompanying their operation. Group II patients also
had a lower mean cardiac output and more common pul-
monary artery pressure than group I (Table IV). Variables
traditionally associated with an increase in case complexity,
length of procedure and total fluid replacement, were
higher in group II compared with group I patients, al-
though these differences did not reach statistical signifi-
cance.
Group II patients had longer hospital and ICU stays
and spent more days on the ventilator, despite the fact that
no differences were seen in preoperative spirometric or
arterial blood gas levels between the groups (Table V). The
mean length of days on the ventilator was significantly
higher in group II even when the patients needing perma-
Preoperative spirometric (A) and arterial blood gas (B) measure-
ments in group I patients compared with group II patients. No
statistically significant differences were seen (mean  standard
deviation).
Table III. Preoperative treatment of COPD in patients





Oral steroids 10% 8%
O2 home use 8% 12%
Inhaler use* 51% 25%
*P  .03, group I compared with group II.
Table IV. Perioperative factors in patients COPD with







Length of procedure (h) 4.1 4.8
Estimated blood loss (L) 1.8 2.1
Blood volume replaced (units)* 2.4 3.6
Fluid replaced (L) 5.8 4.9
Total fluids (L) 6.4 5.9
Cardiac output (L/min) 5.4 4.5
Pulmonary artery diastolic
pressure  20 mm Hg
24% 40%





*P  .05, group I compared with group II.
Table V. Postoperative variables in patients COPD with







Days in ICU* 4.2 14
Days in department* 8.7 11.4
Length of stay* 13 25
Days on ventilator* 0.9 8
Pneumonia 5% 13%
Reintubation* 5.2% 32%
Discharge with oral steroids 14% 8%
Discharge with inhaler 57% 28%
Discharge on O2 13% 12%
Highest creatinine level (mg/dL)* 2.2 2.9
Hematocrit 34% 33%
Readmission 8% 4%
*P  .05, group I compared with group II.
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nent tracheostomy were excluded from the analysis (group
I, 0.9 days; versus group II, 2.7 days; P  .03). This
suggests that factors other than respiratory complications
were associated with the group II morbidity (Table V). No
differences in hospital readmission rates were found among
group I and II patients.
Six patients needed permanent tracheostomy for an
indication of “failure to wean.” Three of these patients
initially underwent extubation but needed reintubation for
respiratory insufficiency, and three were never able to un-
dergo extubation. Four of the six patients had CAD in
addition to COPD, and three were smokers at the time of
surgery. Although no rigid criterion for tracheostomy was
used throughout the 12-year period of this study, patients
who could not be weaned from mechanical ventilation
within 2 weeks usually underwent tracheostomy.
The 30-day mortality rate for the entire cohort of 158
patients with COPD was 3.2% (5/158), of which 80%
(4/5) were men. By definition, all were group II, where the
mortality rate was 20% (5/25). Cardiac disease was the
cause of death in three patients, and two died of multisys-
tem organ failure. No specific variables, either alone or in
combination, were significantly predictive of mortality,
probably because of the small number of deaths in this
series.
Nine patients were discharged to an extended care
facility, including three patients who needed readmission to
the hospital after an earlier discharge home. Three of the
nine were in group II. The only factor associated with
extended care disposition was the overall length of stay,
which averaged 26 days for these patients. Eleven patients
were discharged home with nursing care, and the re-
mainder were discharged home for self care. Ten of these
patients are known to have died, with a mean survival
time of 20 months. Four of these latter patients had a
preoperative history of renal failure, and one needed home
oxygen.
Multivariate analysis of those variables that were statis-
tically significant in the univariate analysis produced a
highly predictive model with a likelihood ratio P value of
.0003. The likelihood ratio P value remained unchanged
when the model was refined to include the preoperative
factors of elevated creatinine level, presence of CAD, and
fewer prescribed inhalers (Table VI). Both elevated creati-
nine level and fewer prescribed inhalers were independently
associated with a poor outcome (P  .01 and .03, respec-
tively). The odds of having a good outcome were three
times greater among those patients using inhalers, and
those with elevated creatinine levels were six times more
likely to have poor results.
DISCUSSION
This study’s findings parallel the documented effects of
COPD in a cohort of 1053 patients, predominantly men,
who underwent AAA repair in the Veterans Administration
Hospitals.4 No differences were seen in mortality in the
latter study, but patients with an ICD-9 diagnosis of
COPD had an extended ICU and hospital length of stay.
Unfortunately, specific variables, such as the severity of
COPD and reliance on oxygen, could not be assessed in this
study because of the administrative nature of the database.
Patients who undergo AAA repair who have pulmonary
embarrassment perioperatively are at increased risk of mor-
bidity regardless of their preoperative pulmonary function.
In one review, pulmonary decompensation was the second
most common morbid event after AAA repair. This oc-
curred in 8% of patients regardless of their preoperative
pulmonary status.5 In a series of 557 patients from the
Cleveland Clinic, 5.7% of patients had postoperative pul-
monary insufficiency develop after aortic surgery.6 Factors
contributing to postoperative pulmonary complications in
the latter study included smoking history, increased age,
duration of anesthetic, and operative blood loss. In our
study, volume of intraoperative blood loss, rather than
preoperative pulmonary function, was the most relevant
factor for the development of pulmonary complications.
Importantly, these complications did not differ in relation
to preoperative pulmonary function tests, a finding similar
to the Cleveland Clinic experience. Although pulmonary
insufficiency after AAA repair may be relatively common,
randomized studies establishing COPD as a preoperative
risk factor for increased mortality are nonexistent. In fact,
some studies with administrative databases have failed to
associate pulmonary disease with increased mortality.7,8
The misconception that patients with COPD are in a
“high-risk” mortality category appears to stem from older
studies of nonaortic upper abdominal surgery and thoracic
surgery.9-11 Although many consider patients with COPD
to be at high risk for death after elective AAA repair, the
overall mortality rate in this cohort of patients with COPD
was only 3.2%. These data do not justify withholding
conventional surgical repair of AAAs or relegating all pa-
tients with COPD to endovascular AAA repair. It would
seem more logical that patients with COPD with AAAs
Table VI. Logistic regression model of patients with COPD with poor outcomes after abdominal aortic
aneurysmectomy
Parameter DF Estimate Standard error Wald 2 P value Odds ratio 95% Confidence limits
Intercept 1 2.6 0.54 23 .0001 – –
Presence of CAD 1 0.88 0.56 2.5 .11 0.4 (0.137, 1.23)
Elevated creatinine level 1 0.47 0.19 5.5 .01 0.63 (0.42, 0.93)
Fewer prescribed inhalers 1 1.15 0.53 4.7 .03 3.14 (1.1, 8.8)
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should undergo whichever procedure is most appropriate
for their disease on the basis of factors other than their
pulmonary disease.
Few studies have identified factors that contribute to
adverse outcomes after elective AAA repair in patients with
COPD. In 1980, a frequently cited series reported on 10
patients with COPD who were considered for surgical
management of AAAs.12 The authors suggested that there
are patients “with serious coexisting disease in whom care-
ful consideration must be given concerning the risk of
operation.” Patients with severe respiratory insufficiency
were an example. They successfully operated on five pa-
tients despite the presence of COPD and suggested that
detailed respiratory assessment, preoperative preparation,
and careful attention to postoperative pulmonary function
were important for success. Despite complicated postoper-
ative courses, none of their patients who had operations
died.
A second series reported seven patients with AAAs who
were oxygen dependent at the time of surgery.13 The
authors of the latter study found a high rate of poor
outcomes but no deaths. They attributed that to a retro-
peritoneal approach with regional anesthesia. In our series,
a transperitoneal surgical approach was used in more than
90% of all patients and in every patient but one with oxygen
dependence. Two deaths occurred among the 13 patients
with oxygen dependence in this group. No significant
association between home oxygen use and postoperative
outcome could be established.
The Hodgkin modification of the Miller criteria is often
cited as predictor of postoperative ventilatory failure in
surgical patients.14,15 Few studies have confirmed the va-
lidity of these criteria in patients undergoing AAA repair. In
fact, Eskandari and associates16 reported no mortality in a
series of 14 patients with oxygen-dependent COPD with a
mean forced expiratory volume in 1 second and forced vital
capacity of 34 and 67%, respectively. They concluded that
home oxygen dependence in patients with COPD is not a
contraindication to elective open AAA repair. Their expe-
rience paralleled that of our series.
Some investigators have suggested that aggressive pre-
operative COPD management might benefit patients un-
dergoing AAA repair. Robison and others17 attempted to
determine whether preoperative steroid use in patients with
severe COPD improved postoperative pulmonary function
after elective AAA repair. A lack of perioperative steroid use
was not associated with postoperative outcome. Results of
our study support this finding. The 16 patients in our series
taking oral steroids before surgery needed intravenous ste-
roids more often during the postoperative period (P 
.009), but this was not associated with an increase in the
incidence of myocardial infarction, renal failure, or respira-
tory failure (P 05, for all comparisons). However, the use
of inhalers was associated with better outcomes (P  .03).
This may be a surrogate for better overall management of
the patient’s COPD before surgery. To date, no prospec-
tive trial has been performed with home oxygen depen-
dence, arterial blood gas values, or pulmonary function
values to determine a level of pulmonary embarrassment
severe enough to preclude AAA repair.
A limitation of this study was an inability to determine
how many patients with COPD were systematically denied
an operation. Vascular surgeons at the authors’ institution
do not routinely deny patients with oxygen-dependent
COPD an operation, but some patients may not have been
referred to a surgeon for treatment by their primary physi-
cian on the basis of poor pulmonary function. A second
limitation was the small number of deaths (3.2%), which
makes it difficult to have sufficient statistical power to
determine specific risk factors for mortality alone.
Factors that affect outcomes in patients with COPD
that might be modified during surgery include closer atten-
tion to the type and amount of replacement fluids. This
appeared as a risk factor in the authors’ patients despite the
routine use of intraoperative and postoperative pulmonary
pressure monitoring, suggesting that a more sensitive
threshold for limiting fluid replacement should be consid-
ered. Speculation is reasonable that fluid restriction and the
earlier use of diuretics may be especially important in those
patients with COPD with coexisting renal failure or con-
gestive heart failure.
Patients with COPD can successively undergo AAA
repair. However, poor outcomes may be anticipated when
they carry the additional risk associated with CAD, respira-
tory insufficiency necessitating continuous oxygen, or
chronic renal insufficiency. Careful attention to these co-
morbidities may modify the risk. In this study, female
gender was not associated with a poor outcome after elec-
tive AAA repair. This is in contrast to an earlier population-
based study of patients in Michigan in which women had a
40% greater risk of dying after elective AAA repair relative
to men.18 In fact, although 12 of the 25 patients in group
II were women, only one death occurred among these
women.
AAA repair can be safely performed for patients with
COPD. However, a group of patients with a higher inci-
dence rate of major clinical complications does exist and
they need additional supportive care. These patients often
have poorer preoperative management of their COPD
along with concurrent cardiac or renal disease. These pa-
tients have prolonged hospital stays, more frequent need
for long-term care, and greater utilization of economic
resources. Recognizing these conditions and taking them
into consideration before AAA repair may reduce their
postoperative morbidity.
We thank Sutten O’Connell, BSN, Charlene Minard,
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tance in preparation of this manuscript.
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